Afinitor and Zits - a phase IV clinical study of FDA data
Zits is found among people who take Afinitor, especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months.
The phase IV clinical study analyzes which people take Afinitor and have Zits. It is created by eHealthMe based on reports of 39,807 people who have side effects when taking Afinitor from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
39,807 people reported to have side effects when taking Afinitor.
Among them, 645 people (1.62%) have Zits.
What is Afinitor?
Afinitor has active ingredients of everolimus. It is often used in breast cancer metastatic. eHealthMe is studying from 39,878 Afinitor users for its effectiveness, alternative drugs and more.
What is Zits?
Zits (pimple/small skin inflammations or lesions/acne) is found to be associated with 2,795 drugs and 2,232 conditions by eHealthMe.
Number of Afinitor and Zits reports submitted per year:
Time on Afinitor when people have Zits *:
Gender of people who have Zits when taking Afinitor*:
Age of people who have Zits when taking Afinitor *:
Common drugs people take besides Afinitor *:
Common side effects people have besides Zits *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Afinitor and have Zits?Check whether Zits is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Zits and when was it recovered:
Expand to all the drugs that have ingredients of everolimus:
- Zits and drugs with ingredients of everolimus (694 reports)
Alternative drugs to, pros and cons of Afinitor:
- Afinitor (39,878 reports)
Common Afinitor side effects:
- Death: 5,716 reports
- Fatigue (feeling of tiredness): 4,180 reports
- Diarrhea: 3,836 reports
- Breathing difficulty: 2,776 reports
- Rashes (redness): 2,725 reports
- Pneumonia: 2,409 reports
Browse all side effects of Afinitor:a b c d e f g h i j k l m n o p q r s t u v w x y z
Zits treatments and more:
- Zits (164,861 reports)
COVID vaccines that are related to Zits:
- Zits in Moderna COVID Vaccine
- Zits in Pfizer BioNTech Covid Vaccine
- Zits in Johnson and Johnson Covid Vaccine
Common drugs associated with Zits:
- Adapalene: 37,062 reports
- Green tea: 16,709 reports
- Prednisone: 1,914 reports
- Mirena: 1,856 reports
- Humira: 1,786 reports
- Enbrel: 1,599 reports
- Accutane: 1,500 reports
- Methotrexate: 1,338 reports
- Vitamins: 1,267 reports
- Xeljanz: 1,138 reports
All the drugs that are associated with Zits:
- Zits (2,795 drugs)
Common conditions associated with Zits:
- Acne: 25,066 reports
- Birth control: 2,621 reports
- Rheumatoid arthritis: 2,294 reports
- Crohn's disease: 1,440 reports
- Multiple sclerosis: 1,113 reports
All the conditions that are associated with Zits:
- Zits (2,232 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on everolimus (the active ingredients of Afinitor) and Afinitor (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Colecalciferol and Weight Loss - now
- Levetiracetam and Gemfibrozil drug interaction - 4 seconds ago
- Paragard T 380A and Hysterectomy - 8 seconds ago
- Botox and Fentanyl Transdermal System drug interaction - 16 seconds ago
- Trousseau'S Syndrome and Coughing Up Blood - 17 seconds ago
- Glipizide and Rybelsus drug interaction - 22 seconds ago
- Triamcinolone Acetonide and Application Site Alopecia - 27 seconds ago
- Valproate Sodium and Oculomucocutaneous Syndrome - 31 seconds ago
- Samsca and Tumor Haemorrhage - 38 seconds ago
- Neupogen and Cardiac Enzymes Increased - 41 seconds ago